HCG, kisspeptin, and enclomiphene: sorting hype from hormonal reality
Quick answer
The creator describes a self-administered stack of HCG, enclomiphene, and kisspeptin intended to raise endogenous testosterone without suppressing the HPG axis, framing it as a middle ground between full TRT and a fully natural hormonal state. He reports a personal testosterone increase from approximately 800 ng/dL to 1,600 ng/dL, which he attributes to the combined use of all three compounds over two months. Each compound has legitimate clinical or research literature supporting its effect on the HPG axis, but the safety profile of this specific combination, particularly regarding estradiol elevation, LH receptor desensitization from chronic HCG use, and kisspeptin receptor downregulation, has not been studied as a stack in controlled trials.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @moreroidsmorefoidz actually say?
The creator claims a stack of HCG, enclomiphene (which he calls "chlomethine"), and kisspeptin is "the best half naddy test boosting stack." He says his testosterone went from 800 ng/dL to over 1,600 ng/dL over two months. He also says none of these compounds affect natural production, no post-cycle therapy is needed, and they are a viable alternative to TRT for men who want to stay "half naddy" (partially natural).
He also acknowledged that HCG gave him "high estrogenic effects," which is one of the few things he said that holds up to scrutiny. The rest of the video is a mixed bag of partly correct mechanisms, some genuine misconceptions, and a few claims that are either unverifiable or just wrong.
Does the science back this up?
Partially. Each compound does have real mechanisms for raising testosterone, but calling this stack consequence-free is where the video falls apart.
HCG (human chorionic gonadotropin) mimics luteinizing hormone (LH) and directly stimulates Leydig cells to produce testosterone. That part is well-documented. But long-term HCG use can desensitize LH receptors, which is the opposite of what he implies. A study by Liu et al. (2002, Journal of Clinical Endocrinology and Metabolism) confirmed HCG raises testosterone but also suppresses pituitary LH output through negative feedback, meaning it does affect your natural hormonal axis.
Enclomiphene is a selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the hypothalamus, raising GnRH, LH, and FSH. Kim et al. (2016, BJU International) showed enclomiphene raised testosterone while preserving sperm production better than TRT. That is a real advantage. Kisspeptin is a neuropeptide that stimulates GnRH release. Small clinical trials, including work by Jayasena et al. (2014, Clinical Endocrinology), show it can acutely raise LH and testosterone, but sustained daily use is complicated by rapid receptor desensitization.
What did they get wrong (or right)?
He got the basic mechanism right: all three compounds work upstream of testosterone production. Credit where it is due. The problem is in what he glossed over.
Saying these compounds "don't affect your natural production" is simply incorrect. HCG suppresses pituitary LH because your body senses high testosterone and dials back. That is textbook negative feedback. Enclomiphene works by blocking estrogen signals at the hypothalamus, which means it is actively interfering with a normal regulatory loop. Calling that "not affecting natural production" is misleading by any reasonable interpretation.
His claim that "you don't need post-cycle therapy" is also shaky. While enclomiphene is sometimes used as post-cycle therapy itself, suddenly stopping HCG after extended use can cause a temporary LH and testosterone drop, which he actually hints at when he mentions "a little bit of a rebound." That rebound is the thing he says is not a problem, while simultaneously admitting it exists.
- HCG does raise testosterone but also raises estradiol, which he acknowledged.
- Enclomiphene has clinical backing as a testosterone-raising agent with fewer fertility side effects than TRT.
- Kisspeptin's effectiveness in a daily oral or injection protocol for long-term use is not well established.
- His personal anecdote of 800 to 1,600 ng/dL is unverifiable and does not constitute evidence.
What should you actually know?
If you are a man with clinically low testosterone and want to preserve fertility, enclomiphene specifically has a reasonable evidence base and is being used by some licensed clinicians. That is a legitimate conversation to have with a doctor. The rest of this stack is more complicated.
Kisspeptin therapy is still largely experimental outside of reproductive medicine research contexts. Pulsatile dosing matters enormously for this compound, and continuous exposure causes rapid receptor downregulation (Seminara et al., 2003, New England Journal of Medicine). The idea that you can just "take" kisspeptin daily and get sustained testosterone elevation oversimplifies the biology significantly.
HCG has real clinical uses, including in men on TRT who want to maintain testicular function. But it is a prescription medication in the United States, and sourcing it outside of a licensed provider carries regulatory and purity risks. The estrogenic side effects he mentioned, including potential gynecomastia and mood changes, are not minor afterthoughts.
No one should build a hormone stack based on a TikTok video. These are compounds that interact with your hypothalamic-pituitary-gonadal axis. Get bloodwork. Talk to a licensed provider who can actually review your labs.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For HCG, kisspeptin, and enclomiphene: sorting hype from hormonal reality, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With HSDD: A Randomized Clinical Trial
Double-blind placebo-controlled crossover in 32 men where kisspeptin modulated sexual brain networks and increased penile tumescence versus placebo.
PubMed
Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
Double-masked placebo-controlled crossover in 32 premenopausal women showing kisspeptin modulated sexual and attraction brain processing.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
HCG, kisspeptin, and enclomiphene: sorting hype from hormonal reality is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator describes a self-administered stack of HCG, enclomiphene, and kisspeptin intended to raise endogenous testosterone without suppressing the HPG axis, framing it as a middle ground between full TRT and a fully natural hormonal state.
FormBlends verdict
The creator describes a self-administered stack of HCG, enclomiphene, and kisspeptin intended to raise endogenous testosterone without suppressing the HPG axis, framing it as a middle ground between full TRT and a fully natural hormonal state. He reports a personal testosterone increase from approximately 800 ng/dL to 1,600 ng/dL, which he attributes to the combined use of all three compounds over two months. Each compound has legitimate clinical or research literature supporting its effect on the HPG axis, but the safety profile of this specific combination, particularly regarding estradiol elevation, LH receptor desensitization from chronic HCG use, and kisspeptin receptor downregulation, has not been studied as a stack in controlled trials.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes a self-administered stack of HCG, enclomiphene, and kisspeptin intended to raise endogenous testosterone without suppressing the HPG axis, framing it as a middle ground between full TRT and a fully natural hormonal state. He reports a personal testosterone increase from approximately 800 ng/dL to 1,600 ng/dL, which he attributes to the combined use of all three compounds over two months. Each compound has legitimate clinical or research literature supporting its effect on the HPG axis, but the safety profile of this specific combination, particularly regarding estradiol elevation, LH receptor desensitization from chronic HCG use, and kisspeptin receptor downregulation, has not been studied as a stack in controlled trials.
- Enclomiphene has the strongest clinical evidence of the three compounds: Kim et al. (2016, BJU International) showed it raised testosterone while preserving sperm counts, unlike TRT.
- HCG mimics LH but does not raise it. Long-term use suppresses pituitary LH output through negative feedback, contradicting the creator's claim that it preserves natural production.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Enclomiphene has the strongest clinical evidence of the three compounds: Kim et al. (2016, BJU International) showed it raised testosterone while preserving sperm counts, unlike TRT.
- HCG mimics LH but does not raise it. Long-term use suppresses pituitary LH output through negative feedback, contradicting the creator's claim that it preserves natural production.
- Kisspeptin causes rapid receptor desensitization with continuous use. Seminara et al. (2003, NEJM) established that pulsatile, not continuous, dosing is required for sustained GnRH stimulation.
- HCG reliably raises estradiol alongside testosterone. This is not a minor side effect. Gynecomastia and mood changes are documented risks that require monitoring, not a brief disclaimer.
- The creator's personal testosterone result of 800 to 1,600 ng/dL is an anecdote, not evidence. It is unverifiable, uncontrolled, and cannot establish which compound, or combination, caused the change.
- All three compounds interact with the hypothalamic-pituitary-gonadal axis. Using them without baseline bloodwork, ongoing labs, and clinical oversight is not a low-risk experiment.
- HCG is a prescription medication in the United States. Sourcing it outside a licensed provider carries legal risk and raises serious questions about product purity and dosing accuracy.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
moreroidsmorefoidz · TikTok creator
11.7K views on this video
#peptide #hcg #kisspeptin #enclomiphene #testosteronebooster
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by moreroidsmorefoidz, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.